Ranolazine for treatment of chronic stable angina

MOspace/Manakin Repository

Breadcrumbs Navigation

Ranolazine for treatment of chronic stable angina

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/7317

[+] show full item record


Title: Ranolazine for treatment of chronic stable angina
Author: Holt, Rebecca; Pettinger, Tracy K.; Routson, Jay
Keywords: cardiovascular events
adjunctive therapy
Date: 2008-05
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 11(5): 10+.
Abstract: Ranolazine (Ranexa®) was approved by the US Food and Drug Administration for the treatment of patients with chronic stable angina in combination with amlodipine, beta-blockers, or nitrates in January 2006. Randomized trials have confirmed that ranolazine is effective for decreasing symptoms of angina without effecting blood pressure or heart rate, but the drug has not been shown to significantly reduce the risk of cardiovascular death or recurrent ischemia.
URI: http://hdl.handle.net/10355/7317

This item appears in the following Collection(s)

[+] show full item record